Location History:
- Ypsilanti, MI (US) (1996 - 1997)
- Middletown, CT (US) (2001 - 2003)
- Ann Arbor, MI (US) (2005 - 2007)
Company Filing History:
11 out of 2,538 
1 out of 3,684 
Years Active: 1996-2007
Title: Amy Mae Bunker: Innovator in Pharmaceutical Chemistry
Introduction
Amy Mae Bunker is a distinguished inventor based in Ann Arbor, MI (US), known for her significant contributions to pharmaceutical chemistry. With a total of 11 patents to her name, she has made remarkable strides in developing innovative compounds that target various medical conditions.
Latest Patents
Among her latest patents, Bunker has developed hetero biaryl derivatives as matrix metalloproteinase inhibitors. This invention provides compounds defined by Formula I and pharmaceutically acceptable salts thereof, along with pharmaceutical compositions that include these compounds. The invention also outlines methods for treating osteo- and rheumatoid arthritis. Another notable patent involves azaisoquinoline derivatives as matrix metalloproteinase inhibitors. This invention similarly provides compounds defined by Formula I and their pharmaceutically acceptable salts, with applications in treating diseases mediated by the MMP-13 enzyme. These diseases include heart disease, multiple sclerosis, and various forms of arthritis, among others.
Career Highlights
Bunker has worked with prominent companies in the pharmaceutical industry, including Warner-Lambert Company and Bristol-Myers Squibb Company. Her work has significantly impacted the development of new therapeutic agents.
Collaborations
Some of her notable coworkers include Jeremy John Edmunds and Xue-Min Cheng, who have collaborated with her on various projects.
Conclusion
Amy Mae Bunker is a pioneering inventor whose work in pharmaceutical chemistry continues to influence the treatment of numerous medical conditions. Her innovative patents and collaborations highlight her commitment to advancing healthcare solutions.